Puriblood Medical Co., Ltd. (TPEX:6847)

Puriblood Medical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	39.78	60.43	86.61	117.48	99.5	131.87
Cash & Short-Term Investments	39.78	60.43	86.61	117.48	99.5	131.87
Cash Growth	-50.74%	-30.23%	-26.28%	18.07%	-24.55%	32.09%
Accounts Receivable	29.93	30.46	14.72	8.4	18.47	8.14
Other Receivables	0.42	0.14	0.18	0.15	0.11	0.05
Receivables	30.35	30.59	14.9	8.56	18.57	8.19
Inventory	28.48	28.37	33.77	24.25	30.86	17.36
Prepaid Expenses	4.92	3.39	1.97	4.37	24.61	17.07
Other Current Assets	0.79	0.78	0.8	-	27.72	-
Total Current Assets	104.31	123.56	138.05	154.66	201.26	174.5
Property, Plant & Equipment	44.06	45.51	49.9	50.78	52.99	57.32
Long-Term Investments	47.04	55.35	55.8	39.2	46.91	23.48
Other Intangible Assets	6.2	7.36	9.68	12.43	15.4	9.08
Long-Term Deferred Tax Assets	1.83	2.96	3.14	2.43	1.29	-
Other Long-Term Assets	1.14	1.94	2.58	6.02	2.66	1.23
Total Assets	204.58	236.68	259.15	265.51	320.5	265.6

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	31.35	27.78	7.95	15.07	3.8	1.94
Accrued Expenses	-	8.75	-	-	-	-
Short-Term Debt	5	5	-	-	-	-
Current Portion of Long-Term Debt	7.82	7.82	4.49	6.66	4.6	2.46
Current Portion of Leases	1.37	1.35	1.32	1.28	1.25	1.21
Current Unearned Revenue	0.54	0.41	0.76	0.51	8.39	0.98
Other Current Liabilities	15.33	7.08	21.75	16.38	16.63	15.27
Total Current Liabilities	61.41	58.19	36.26	39.89	34.66	21.85
Long-Term Debt	14.6	18.51	26.33	22.67	28.46	3.06
Long-Term Leases	17.67	18.36	19.72	21.03	22.31	23.55
Pension & Post-Retirement Benefits	1.41	1.28	1.38	0.76	0.34	0.21
Long-Term Deferred Tax Liabilities	0.11	0.13	0.07	0	1.69	-
Other Long-Term Liabilities	-	-	-	-	-	0.44
Total Liabilities	95.19	96.47	83.75	84.35	87.47	49.11

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	142.3	142.3	142.3	142.3	142.3	142.3
Additional Paid-In Capital	42.53	42.02	38.86	177.83	177.83	177.83
Retained Earnings	-75.45	-44.12	-5.76	-138.97	-87.1	-103.63
Total Common Equity	109.39	140.21	175.4	181.16	233.03	216.5
Shareholders' Equity	109.39	140.21	175.4	181.16	233.03	216.5
Total Liabilities & Equity	204.58	236.68	259.15	265.51	320.5	265.6

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	46.46	51.04	51.85	51.64	56.61	30.28
Net Cash (Debt)	-6.68	9.39	34.77	65.84	42.89	101.59
Net Cash Growth	-	-73.00%	-47.20%	53.53%	-57.79%	53.99%
Net Cash Per Share	-0.47	0.66	2.44	4.63	3.01	8.72
Filing Date Shares Outstanding	14.23	14.23	14.23	14.23	14.23	14.23
Total Common Shares Outstanding	14.23	14.23	14.23	14.23	14.23	14.23
Working Capital	42.9	65.37	101.79	114.76	166.6	152.65
Book Value Per Share	7.69	9.85	12.33	12.73	16.38	15.21
Tangible Book Value	103.18	132.85	165.72	168.73	217.63	207.42
Tangible Book Value Per Share	7.25	9.34	11.65	11.86	15.29	14.58
Machinery	33.08	32.04	30.94	26.67	24.43	23.97
Leasehold Improvements	17.54	17.54	17.54	17.3	16.73	16.81

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 7, 2026

Data Sources Report a data error